Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors.
about
Pelvic radiotherapy and sexual function in womenCancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populationsSexual dysfunction and infertility as late effects of cancer treatment.Undesirable financial effects of head and neck cancer radiotherapy during the initial treatment period.Systematic review of the quality of life issues associated with anal cancer and its treatment with radiochemotherapy.Investigation of body image as a mediator of the effects of bowel and GI symptoms on psychological distress in female survivors of rectal and anal cancerBody image and sexual function in women after treatment for anal and rectal cancer.Biomarkers in anal cancer: from biological understanding to stratified treatment.Anal cancer: current standards in care and recent changes in practice.Nonoperative management of rectal cancer.Survivorship after lower gastrointestinal cancer: Patient-reported outcomes and planning for care.Chemotherapy-induced peripheral neuropathy: A current review.Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapy.Long-term anorectal, urinary and sexual dysfunction causing distress after radiotherapy for anal cancer: a Danish multicentre cross-sectional questionnaire study.Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomographyMultimodal therapy is feasible in elderly anal cancer patients.Management of early anal cancer: need for guidelines and standardisation.Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
P2860
Q26773698-A249C840-C0D2-4CE2-B23B-6D40BE37ADE4Q26799512-748E22A9-B793-4032-A5EA-56CCECD8BC65Q34604454-B17E96D2-1E5F-4616-8A95-679637B3AC73Q35014558-CB846550-E5F6-4CB9-85FA-F4A1805B3D6FQ35750692-81F301CC-EB96-45F9-B122-D6645A1418FAQ36887590-425B8197-4EC1-4071-A9D0-D6750F68CF2BQ37126400-DB6B3429-57AE-4BF7-BA8A-F3CD44372CC3Q37592879-BB43179E-6984-4785-BB83-DD4058F8C0BEQ38315952-FAD0452B-C2D8-49ED-B19B-45AE1313BE0EQ38645219-C0930F78-0FFC-4B91-A1AC-408BCDE21768Q39038666-BE1186E5-13FB-4C49-87AA-1E9D1C516DA1Q39293928-77F77E48-EDD7-470B-940E-6A80EF1FB3EDQ41312134-9944B4DB-A982-4D63-A103-CB5EC21D767EQ41539955-8AC5B345-E1E4-461C-A72C-3A5679F81292Q41625221-CA3F9B10-D252-4386-A5DF-92A5F42C71E0Q42501308-BAB314C9-EB5A-4973-9EF9-3196481B9708Q50072305-849284C4-5E6F-4834-8668-6DC1D312B554Q53508111-D88E2808-6D1F-4EF9-A89D-15833CDCB3AD
P2860
Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Impaired health-related qualit ...... ional cohort of 128 survivors.
@ast
Impaired health-related qualit ...... ional cohort of 128 survivors.
@en
type
label
Impaired health-related qualit ...... ional cohort of 128 survivors.
@ast
Impaired health-related qualit ...... ional cohort of 128 survivors.
@en
prefLabel
Impaired health-related qualit ...... ional cohort of 128 survivors.
@ast
Impaired health-related qualit ...... ional cohort of 128 survivors.
@en
P2093
P2860
P1433
P1476
Impaired health-related qualit ...... ional cohort of 128 survivors.
@en
P2093
Anne Gry Bentzen
Eva Hoff Wanderås
Gunilla Frykholm
Lise Balteskard
Marianne Grønlie Guren
Tom Wilsgaard
P2860
P304
P356
10.3109/0284186X.2013.770599
P50
P577
2013-02-26T00:00:00Z